nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP3A4—prostate cancer	0.105	1	CbGaD
Mianserin—CYP2B6—Estrone—prostate cancer	0.0415	0.0926	CbGbCtD
Mianserin—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0405	0.0903	CbGbCtD
Mianserin—CYP2B6—Ethinyl Estradiol—prostate cancer	0.037	0.0825	CbGbCtD
Mianserin—CYP1A2—Flutamide—prostate cancer	0.0337	0.0751	CbGbCtD
Mianserin—CYP2D6—Bicalutamide—prostate cancer	0.0335	0.0746	CbGbCtD
Mianserin—CYP2D6—Abiraterone—prostate cancer	0.0277	0.0618	CbGbCtD
Mianserin—CYP1A2—Estrone—prostate cancer	0.0243	0.0543	CbGbCtD
Mianserin—CYP3A4—Bicalutamide—prostate cancer	0.0213	0.0475	CbGbCtD
Mianserin—CYP3A4—Estramustine—prostate cancer	0.0198	0.0441	CbGbCtD
Mianserin—CYP3A4—Flutamide—prostate cancer	0.0176	0.0393	CbGbCtD
Mianserin—CYP3A4—Abiraterone—prostate cancer	0.0176	0.0393	CbGbCtD
Mianserin—CYP1A2—Conjugated Estrogens—prostate cancer	0.0159	0.0355	CbGbCtD
Mianserin—CYP1A2—Estradiol—prostate cancer	0.014	0.0312	CbGbCtD
Mianserin—CYP3A4—Cabazitaxel—prostate cancer	0.0131	0.0291	CbGbCtD
Mianserin—CYP3A4—Estrone—prostate cancer	0.0128	0.0284	CbGbCtD
Mianserin—HTR7—vas deferens—prostate cancer	0.0124	0.279	CbGeAlD
Mianserin—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0114	0.0253	CbGbCtD
Mianserin—CYP2B6—Doxorubicin—prostate cancer	0.0106	0.0237	CbGbCtD
Mianserin—CYP1A2—Etoposide—prostate cancer	0.00913	0.0204	CbGbCtD
Mianserin—CYP3A4—Conjugated Estrogens—prostate cancer	0.00835	0.0186	CbGbCtD
Mianserin—CYP3A4—Mitoxantrone—prostate cancer	0.00759	0.0169	CbGbCtD
Mianserin—CYP3A4—Estradiol—prostate cancer	0.00733	0.0163	CbGbCtD
Mianserin—CYP3A4—Prednisone—prostate cancer	0.0063	0.014	CbGbCtD
Mianserin—CYP2D6—Doxorubicin—prostate cancer	0.00513	0.0114	CbGbCtD
Mianserin—CYP3A4—Etoposide—prostate cancer	0.00478	0.0107	CbGbCtD
Mianserin—CYP3A4—Docetaxel—prostate cancer	0.00438	0.00976	CbGbCtD
Mianserin—CYP3A4—Doxorubicin—prostate cancer	0.00326	0.00727	CbGbCtD
Mianserin—HRH4—bone marrow—prostate cancer	0.00268	0.0602	CbGeAlD
Mianserin—CYP1A2—urine—prostate cancer	0.00246	0.0554	CbGeAlD
Mianserin—OPRK1—prostate gland—prostate cancer	0.00221	0.0497	CbGeAlD
Mianserin—HTR2A—urine—prostate cancer	0.00192	0.0433	CbGeAlD
Mianserin—CYP3A4—urine—prostate cancer	0.00178	0.0401	CbGeAlD
Mianserin—CYP2D6—urine—prostate cancer	0.00175	0.0395	CbGeAlD
Mianserin—Cyclizine—SULT1E1—prostate cancer	0.00173	0.294	CrCbGaD
Mianserin—ADRA2C—prostate gland—prostate cancer	0.00102	0.0229	CbGeAlD
Mianserin—ADRA2C—seminal vesicle—prostate cancer	0.000861	0.0194	CbGeAlD
Mianserin—HRH1—prostate gland—prostate cancer	0.000827	0.0186	CbGeAlD
Mianserin—HTR7—epithelium—prostate cancer	0.000814	0.0183	CbGeAlD
Mianserin—ADRA2A—prostate gland—prostate cancer	0.000813	0.0183	CbGeAlD
Mianserin—HTR1A—renal system—prostate cancer	0.00079	0.0178	CbGeAlD
Mianserin—HTR7—renal system—prostate cancer	0.000755	0.017	CbGeAlD
Mianserin—HRH2—lymph node—prostate cancer	0.000696	0.0157	CbGeAlD
Mianserin—ADRA2C—renal system—prostate cancer	0.000694	0.0156	CbGeAlD
Mianserin—ADRA2A—seminal vesicle—prostate cancer	0.000687	0.0155	CbGeAlD
Mianserin—ADRA2C—urethra—prostate cancer	0.000682	0.0154	CbGeAlD
Mianserin—SLC6A3—testis—prostate cancer	0.000628	0.0141	CbGeAlD
Mianserin—HRH1—epithelium—prostate cancer	0.000608	0.0137	CbGeAlD
Mianserin—CYP1A2—renal system—prostate cancer	0.000602	0.0136	CbGeAlD
Mianserin—CYP2B6—renal system—prostate cancer	0.000577	0.013	CbGeAlD
Mianserin—HRH1—urethra—prostate cancer	0.000554	0.0125	CbGeAlD
Mianserin—ADRA2A—urethra—prostate cancer	0.000544	0.0122	CbGeAlD
Mianserin—HTR2A—epithelium—prostate cancer	0.000508	0.0114	CbGeAlD
Mianserin—SLC6A2—testis—prostate cancer	0.000506	0.0114	CbGeAlD
Mianserin—HTR7—testis—prostate cancer	0.000488	0.011	CbGeAlD
Mianserin—HTR2A—renal system—prostate cancer	0.000471	0.0106	CbGeAlD
Mianserin—DRD2—testis—prostate cancer	0.000462	0.0104	CbGeAlD
Mianserin—ADRA2C—testis—prostate cancer	0.000449	0.0101	CbGeAlD
Mianserin—CYP3A4—renal system—prostate cancer	0.000436	0.00982	CbGeAlD
Mianserin—CYP2D6—renal system—prostate cancer	0.000429	0.00966	CbGeAlD
Mianserin—HTR2B—lymph node—prostate cancer	0.000413	0.0093	CbGeAlD
Mianserin—CYP2B6—testis—prostate cancer	0.000373	0.0084	CbGeAlD
Mianserin—SLC6A2—lymph node—prostate cancer	0.000367	0.00826	CbGeAlD
Mianserin—HRH1—testis—prostate cancer	0.000364	0.0082	CbGeAlD
Mianserin—ADRA2A—testis—prostate cancer	0.000358	0.00806	CbGeAlD
Mianserin—ADRA2C—lymph node—prostate cancer	0.000325	0.00732	CbGeAlD
Mianserin—HTR2A—testis—prostate cancer	0.000304	0.00685	CbGeAlD
Mianserin—Oxcarbazepine—CYP3A5—prostate cancer	0.000284	0.0483	CrCbGaD
Mianserin—CYP2D6—testis—prostate cancer	0.000277	0.00624	CbGeAlD
Mianserin—HRH1—lymph node—prostate cancer	0.000264	0.00595	CbGeAlD
Mianserin—ADRA2A—lymph node—prostate cancer	0.000259	0.00584	CbGeAlD
Mianserin—Azatadine—CYP3A4—prostate cancer	0.00023	0.0392	CrCbGaD
Mianserin—Desipramine—SLC22A3—prostate cancer	0.000226	0.0386	CrCbGaD
Mianserin—Desipramine—CYP2C18—prostate cancer	0.000199	0.0339	CrCbGaD
Mianserin—Oxcarbazepine—CYP2C19—prostate cancer	0.000193	0.0329	CrCbGaD
Mianserin—Imipramine—SLC22A3—prostate cancer	0.000192	0.0327	CrCbGaD
Mianserin—Mirtazapine—ADRB2—prostate cancer	0.000192	0.0326	CrCbGaD
Mianserin—Paraesthesia—Mitoxantrone—prostate cancer	0.000187	0.000863	CcSEcCtD
Mianserin—Loss of consciousness—Etoposide—prostate cancer	0.000187	0.000861	CcSEcCtD
Mianserin—Lethargy—Doxorubicin—prostate cancer	0.000187	0.000861	CcSEcCtD
Mianserin—Dizziness—Goserelin—prostate cancer	0.000186	0.000861	CcSEcCtD
Mianserin—Somnolence—Mitoxantrone—prostate cancer	0.000185	0.000855	CcSEcCtD
Mianserin—Dizziness—Conjugated Estrogens—prostate cancer	0.000185	0.000853	CcSEcCtD
Mianserin—Feeling abnormal—Estradiol—prostate cancer	0.000184	0.00085	CcSEcCtD
Mianserin—Convulsion—Etoposide—prostate cancer	0.000184	0.000849	CcSEcCtD
Mianserin—Angiopathy—Docetaxel—prostate cancer	0.000184	0.000849	CcSEcCtD
Mianserin—Eye disorder—Capecitabine—prostate cancer	0.000183	0.000846	CcSEcCtD
Mianserin—Hypertension—Etoposide—prostate cancer	0.000183	0.000846	CcSEcCtD
Mianserin—Tinnitus—Capecitabine—prostate cancer	0.000183	0.000844	CcSEcCtD
Mianserin—Diplopia—Doxorubicin—prostate cancer	0.000183	0.000844	CcSEcCtD
Mianserin—Mediastinal disorder—Docetaxel—prostate cancer	0.000183	0.000843	CcSEcCtD
Mianserin—Cardiac disorder—Capecitabine—prostate cancer	0.000182	0.000841	CcSEcCtD
Mianserin—Fatigue—Mitoxantrone—prostate cancer	0.00018	0.000829	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000179	0.000828	CcSEcCtD
Mianserin—Breast disorder—Epirubicin—prostate cancer	0.000179	0.000824	CcSEcCtD
Mianserin—Constipation—Mitoxantrone—prostate cancer	0.000178	0.000822	CcSEcCtD
Mianserin—Angiopathy—Capecitabine—prostate cancer	0.000178	0.000822	CcSEcCtD
Mianserin—Bradycardia—Prednisone—prostate cancer	0.000178	0.000821	CcSEcCtD
Mianserin—Rash—Goserelin—prostate cancer	0.000178	0.000821	CcSEcCtD
Mianserin—Dermatitis—Goserelin—prostate cancer	0.000178	0.00082	CcSEcCtD
Mianserin—Mental disorder—Docetaxel—prostate cancer	0.000178	0.00082	CcSEcCtD
Mianserin—Mediastinal disorder—Capecitabine—prostate cancer	0.000177	0.000816	CcSEcCtD
Mianserin—Headache—Goserelin—prostate cancer	0.000177	0.000815	CcSEcCtD
Mianserin—Rash—Conjugated Estrogens—prostate cancer	0.000176	0.000813	CcSEcCtD
Mianserin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000176	0.000812	CcSEcCtD
Mianserin—Headache—Conjugated Estrogens—prostate cancer	0.000175	0.000808	CcSEcCtD
Mianserin—Confusional state—Etoposide—prostate cancer	0.000175	0.000806	CcSEcCtD
Mianserin—Cardiac arrest—Doxorubicin—prostate cancer	0.000174	0.000802	CcSEcCtD
Mianserin—Mental disorder—Capecitabine—prostate cancer	0.000172	0.000794	CcSEcCtD
Mianserin—Connective tissue disorder—Prednisone—prostate cancer	0.000172	0.000793	CcSEcCtD
Mianserin—Feeling abnormal—Mitoxantrone—prostate cancer	0.000172	0.000792	CcSEcCtD
Mianserin—Thrombocytopenia—Etoposide—prostate cancer	0.00017	0.000783	CcSEcCtD
Mianserin—Tachycardia—Etoposide—prostate cancer	0.000169	0.000781	CcSEcCtD
Mianserin—Imipramine—CYP2C18—prostate cancer	0.000169	0.0287	CrCbGaD
Mianserin—Skin disorder—Etoposide—prostate cancer	0.000168	0.000777	CcSEcCtD
Mianserin—Breast disorder—Doxorubicin—prostate cancer	0.000165	0.000763	CcSEcCtD
Mianserin—Eye disorder—Prednisone—prostate cancer	0.000163	0.000754	CcSEcCtD
Mianserin—Anaemia—Docetaxel—prostate cancer	0.000163	0.000753	CcSEcCtD
Mianserin—Desipramine—SLC22A1—prostate cancer	0.000162	0.0277	CrCbGaD
Mianserin—Pancytopenia—Epirubicin—prostate cancer	0.000162	0.000749	CcSEcCtD
Mianserin—Hypotension—Etoposide—prostate cancer	0.000162	0.000747	CcSEcCtD
Mianserin—Asthenia—Estradiol—prostate cancer	0.00016	0.00074	CcSEcCtD
Mianserin—Tremor—Capecitabine—prostate cancer	0.00016	0.000739	CcSEcCtD
Mianserin—Neutropenia—Epirubicin—prostate cancer	0.00016	0.000737	CcSEcCtD
Mianserin—Nortriptyline—CYP3A5—prostate cancer	0.000159	0.0271	CrCbGaD
Mianserin—Angiopathy—Prednisone—prostate cancer	0.000159	0.000732	CcSEcCtD
Mianserin—Syncope—Docetaxel—prostate cancer	0.000158	0.00073	CcSEcCtD
Mianserin—Pruritus—Estradiol—prostate cancer	0.000158	0.00073	CcSEcCtD
Mianserin—Leukopenia—Docetaxel—prostate cancer	0.000158	0.000729	CcSEcCtD
Mianserin—Anaemia—Capecitabine—prostate cancer	0.000158	0.000729	CcSEcCtD
Mianserin—Paraesthesia—Etoposide—prostate cancer	0.000156	0.000718	CcSEcCtD
Mianserin—Weight increased—Epirubicin—prostate cancer	0.000155	0.000717	CcSEcCtD
Mianserin—Loss of consciousness—Docetaxel—prostate cancer	0.000155	0.000716	CcSEcCtD
Mianserin—Somnolence—Etoposide—prostate cancer	0.000154	0.000711	CcSEcCtD
Mianserin—Vertigo—Capecitabine—prostate cancer	0.000153	0.000708	CcSEcCtD
Mianserin—Syncope—Capecitabine—prostate cancer	0.000153	0.000707	CcSEcCtD
Mianserin—Mental disorder—Prednisone—prostate cancer	0.000153	0.000707	CcSEcCtD
Mianserin—Leukopenia—Capecitabine—prostate cancer	0.000153	0.000706	CcSEcCtD
Mianserin—Convulsion—Docetaxel—prostate cancer	0.000153	0.000706	CcSEcCtD
Mianserin—Hypertension—Docetaxel—prostate cancer	0.000152	0.000703	CcSEcCtD
Mianserin—Drowsiness—Epirubicin—prostate cancer	0.000152	0.000703	CcSEcCtD
Mianserin—Myalgia—Docetaxel—prostate cancer	0.00015	0.000693	CcSEcCtD
Mianserin—Arthralgia—Docetaxel—prostate cancer	0.00015	0.000693	CcSEcCtD
Mianserin—Loss of consciousness—Capecitabine—prostate cancer	0.00015	0.000693	CcSEcCtD
Mianserin—Pancytopenia—Doxorubicin—prostate cancer	0.00015	0.000693	CcSEcCtD
Mianserin—Gastrointestinal disorder—Etoposide—prostate cancer	0.00015	0.00069	CcSEcCtD
Mianserin—Asthenia—Mitoxantrone—prostate cancer	0.000149	0.00069	CcSEcCtD
Mianserin—Fatigue—Etoposide—prostate cancer	0.000149	0.000689	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000149	0.000689	CcSEcCtD
Mianserin—Jaundice—Epirubicin—prostate cancer	0.000148	0.000685	CcSEcCtD
Mianserin—Constipation—Etoposide—prostate cancer	0.000148	0.000684	CcSEcCtD
Mianserin—Dizziness—Estradiol—prostate cancer	0.000148	0.000682	CcSEcCtD
Mianserin—Neutropenia—Doxorubicin—prostate cancer	0.000148	0.000682	CcSEcCtD
Mianserin—Hypertension—Capecitabine—prostate cancer	0.000147	0.000681	CcSEcCtD
Mianserin—Dry mouth—Docetaxel—prostate cancer	0.000147	0.000678	CcSEcCtD
Mianserin—Myalgia—Capecitabine—prostate cancer	0.000145	0.000671	CcSEcCtD
Mianserin—Arthralgia—Capecitabine—prostate cancer	0.000145	0.000671	CcSEcCtD
Mianserin—Confusional state—Docetaxel—prostate cancer	0.000145	0.00067	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000144	0.000667	CcSEcCtD
Mianserin—Hepatobiliary disease—Epirubicin—prostate cancer	0.000144	0.000665	CcSEcCtD
Mianserin—Oedema—Docetaxel—prostate cancer	0.000144	0.000665	CcSEcCtD
Mianserin—Weight increased—Doxorubicin—prostate cancer	0.000144	0.000664	CcSEcCtD
Mianserin—Feeling abnormal—Etoposide—prostate cancer	0.000143	0.000659	CcSEcCtD
Mianserin—Dry mouth—Capecitabine—prostate cancer	0.000142	0.000656	CcSEcCtD
Mianserin—Agranulocytosis—Epirubicin—prostate cancer	0.000142	0.000656	CcSEcCtD
Mianserin—Shock—Docetaxel—prostate cancer	0.000142	0.000654	CcSEcCtD
Mianserin—Nervous system disorder—Docetaxel—prostate cancer	0.000141	0.000652	CcSEcCtD
Mianserin—Thrombocytopenia—Docetaxel—prostate cancer	0.000141	0.000651	CcSEcCtD
Mianserin—Rash—Estradiol—prostate cancer	0.000141	0.000651	CcSEcCtD
Mianserin—Drowsiness—Doxorubicin—prostate cancer	0.000141	0.00065	CcSEcCtD
Mianserin—Dermatitis—Estradiol—prostate cancer	0.000141	0.00065	CcSEcCtD
Mianserin—Anaemia—Prednisone—prostate cancer	0.000141	0.000649	CcSEcCtD
Mianserin—Confusional state—Capecitabine—prostate cancer	0.000141	0.000649	CcSEcCtD
Mianserin—Tachycardia—Docetaxel—prostate cancer	0.000141	0.000649	CcSEcCtD
Mianserin—Headache—Estradiol—prostate cancer	0.00014	0.000646	CcSEcCtD
Mianserin—Skin disorder—Docetaxel—prostate cancer	0.00014	0.000646	CcSEcCtD
Mianserin—Agitation—Prednisone—prostate cancer	0.00014	0.000645	CcSEcCtD
Mianserin—Oedema—Capecitabine—prostate cancer	0.000139	0.000643	CcSEcCtD
Mianserin—Bradycardia—Epirubicin—prostate cancer	0.000139	0.000642	CcSEcCtD
Mianserin—Imipramine—SLC22A1—prostate cancer	0.000138	0.0235	CrCbGaD
Mianserin—Jaundice—Doxorubicin—prostate cancer	0.000137	0.000634	CcSEcCtD
Mianserin—Shock—Capecitabine—prostate cancer	0.000137	0.000633	CcSEcCtD
Mianserin—Nervous system disorder—Capecitabine—prostate cancer	0.000137	0.000631	CcSEcCtD
Mianserin—Vertigo—Prednisone—prostate cancer	0.000137	0.000631	CcSEcCtD
Mianserin—Hepatitis—Epirubicin—prostate cancer	0.000137	0.000631	CcSEcCtD
Mianserin—Thrombocytopenia—Capecitabine—prostate cancer	0.000136	0.00063	CcSEcCtD
Mianserin—Syncope—Prednisone—prostate cancer	0.000136	0.00063	CcSEcCtD
Mianserin—Tachycardia—Capecitabine—prostate cancer	0.000136	0.000628	CcSEcCtD
Mianserin—Skin disorder—Capecitabine—prostate cancer	0.000135	0.000625	CcSEcCtD
Mianserin—Hypotension—Docetaxel—prostate cancer	0.000135	0.000621	CcSEcCtD
Mianserin—Connective tissue disorder—Epirubicin—prostate cancer	0.000134	0.00062	CcSEcCtD
Mianserin—Loss of consciousness—Prednisone—prostate cancer	0.000134	0.000617	CcSEcCtD
Mianserin—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000133	0.000615	CcSEcCtD
Mianserin—Epinastine—CYP3A4—prostate cancer	0.000133	0.0227	CrCbGaD
Mianserin—Convulsion—Prednisone—prostate cancer	0.000132	0.000608	CcSEcCtD
Mianserin—Agranulocytosis—Doxorubicin—prostate cancer	0.000131	0.000607	CcSEcCtD
Mianserin—Hypertension—Prednisone—prostate cancer	0.000131	0.000606	CcSEcCtD
Mianserin—Rash—Mitoxantrone—prostate cancer	0.000131	0.000606	CcSEcCtD
Mianserin—Dermatitis—Mitoxantrone—prostate cancer	0.000131	0.000606	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000131	0.000606	CcSEcCtD
Mianserin—Headache—Mitoxantrone—prostate cancer	0.00013	0.000602	CcSEcCtD
Mianserin—Hypotension—Capecitabine—prostate cancer	0.00013	0.000601	CcSEcCtD
Mianserin—Arthralgia—Prednisone—prostate cancer	0.00013	0.000598	CcSEcCtD
Mianserin—Myalgia—Prednisone—prostate cancer	0.00013	0.000598	CcSEcCtD
Mianserin—Paraesthesia—Docetaxel—prostate cancer	0.000129	0.000597	CcSEcCtD
Mianserin—Bradycardia—Doxorubicin—prostate cancer	0.000129	0.000594	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000129	0.000594	CcSEcCtD
Mianserin—Somnolence—Docetaxel—prostate cancer	0.000128	0.000591	CcSEcCtD
Mianserin—Eye disorder—Epirubicin—prostate cancer	0.000128	0.00059	CcSEcCtD
Mianserin—Tinnitus—Epirubicin—prostate cancer	0.000127	0.000588	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000127	0.000586	CcSEcCtD
Mianserin—Cardiac disorder—Epirubicin—prostate cancer	0.000127	0.000586	CcSEcCtD
Mianserin—Desipramine—CYP2A6—prostate cancer	0.000127	0.0216	CrCbGaD
Mianserin—Hepatitis—Doxorubicin—prostate cancer	0.000126	0.000584	CcSEcCtD
Mianserin—Mequitazine—CYP3A4—prostate cancer	0.000125	0.0213	CrCbGaD
Mianserin—Paraesthesia—Capecitabine—prostate cancer	0.000125	0.000578	CcSEcCtD
Mianserin—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000124	0.000574	CcSEcCtD
Mianserin—Asthenia—Etoposide—prostate cancer	0.000124	0.000574	CcSEcCtD
Mianserin—Connective tissue disorder—Doxorubicin—prostate cancer	0.000124	0.000574	CcSEcCtD
Mianserin—Oedema—Prednisone—prostate cancer	0.000124	0.000573	CcSEcCtD
Mianserin—Fatigue—Docetaxel—prostate cancer	0.000124	0.000573	CcSEcCtD
Mianserin—Angiopathy—Epirubicin—prostate cancer	0.000124	0.000572	CcSEcCtD
Mianserin—Mediastinal disorder—Epirubicin—prostate cancer	0.000123	0.000569	CcSEcCtD
Mianserin—Constipation—Docetaxel—prostate cancer	0.000123	0.000568	CcSEcCtD
Mianserin—Oxcarbazepine—CYP3A4—prostate cancer	0.000123	0.0209	CrCbGaD
Mianserin—Pruritus—Etoposide—prostate cancer	0.000123	0.000566	CcSEcCtD
Mianserin—Shock—Prednisone—prostate cancer	0.000122	0.000564	CcSEcCtD
Mianserin—Nervous system disorder—Prednisone—prostate cancer	0.000122	0.000562	CcSEcCtD
Mianserin—Tachycardia—Prednisone—prostate cancer	0.000121	0.000559	CcSEcCtD
Mianserin—Skin disorder—Prednisone—prostate cancer	0.000121	0.000557	CcSEcCtD
Mianserin—Gastrointestinal disorder—Capecitabine—prostate cancer	0.00012	0.000556	CcSEcCtD
Mianserin—Fatigue—Capecitabine—prostate cancer	0.00012	0.000555	CcSEcCtD
Mianserin—Mental disorder—Epirubicin—prostate cancer	0.00012	0.000553	CcSEcCtD
Mianserin—Constipation—Capecitabine—prostate cancer	0.000119	0.00055	CcSEcCtD
Mianserin—Feeling abnormal—Docetaxel—prostate cancer	0.000119	0.000548	CcSEcCtD
Mianserin—Eye disorder—Doxorubicin—prostate cancer	0.000118	0.000546	CcSEcCtD
Mianserin—Tinnitus—Doxorubicin—prostate cancer	0.000118	0.000544	CcSEcCtD
Mianserin—Cardiac disorder—Doxorubicin—prostate cancer	0.000117	0.000542	CcSEcCtD
Mianserin—Feeling abnormal—Capecitabine—prostate cancer	0.000115	0.00053	CcSEcCtD
Mianserin—Angiopathy—Doxorubicin—prostate cancer	0.000115	0.00053	CcSEcCtD
Mianserin—Dizziness—Etoposide—prostate cancer	0.000115	0.000529	CcSEcCtD
Mianserin—Mediastinal disorder—Doxorubicin—prostate cancer	0.000114	0.000526	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000113	0.000522	CcSEcCtD
Mianserin—Paraesthesia—Prednisone—prostate cancer	0.000112	0.000515	CcSEcCtD
Mianserin—Mental disorder—Doxorubicin—prostate cancer	0.000111	0.000511	CcSEcCtD
Mianserin—Amitriptyline—CYP3A5—prostate cancer	0.00011	0.0188	CrCbGaD
Mianserin—Anaemia—Epirubicin—prostate cancer	0.00011	0.000508	CcSEcCtD
Mianserin—Nortriptyline—CYP2E1—prostate cancer	0.000109	0.0186	CrCbGaD
Mianserin—Agitation—Epirubicin—prostate cancer	0.000109	0.000505	CcSEcCtD
Mianserin—Rash—Etoposide—prostate cancer	0.000109	0.000504	CcSEcCtD
Mianserin—Dermatitis—Etoposide—prostate cancer	0.000109	0.000504	CcSEcCtD
Mianserin—Headache—Etoposide—prostate cancer	0.000109	0.000501	CcSEcCtD
Mianserin—Nortriptyline—CYP2C19—prostate cancer	0.000108	0.0184	CrCbGaD
Mianserin—Fatigue—Prednisone—prostate cancer	0.000107	0.000494	CcSEcCtD
Mianserin—Vertigo—Epirubicin—prostate cancer	0.000107	0.000493	CcSEcCtD
Mianserin—Syncope—Epirubicin—prostate cancer	0.000107	0.000493	CcSEcCtD
Mianserin—Leukopenia—Epirubicin—prostate cancer	0.000107	0.000492	CcSEcCtD
Mianserin—Constipation—Prednisone—prostate cancer	0.000106	0.00049	CcSEcCtD
Mianserin—Mirtazapine—CYP3A4—prostate cancer	0.000105	0.0179	CrCbGaD
Mianserin—Loss of consciousness—Epirubicin—prostate cancer	0.000105	0.000483	CcSEcCtD
Mianserin—Desipramine—ADRB2—prostate cancer	0.000104	0.0176	CrCbGaD
Mianserin—Asthenia—Docetaxel—prostate cancer	0.000103	0.000477	CcSEcCtD
Mianserin—Convulsion—Epirubicin—prostate cancer	0.000103	0.000476	CcSEcCtD
Mianserin—Hypertension—Epirubicin—prostate cancer	0.000103	0.000474	CcSEcCtD
Mianserin—Feeling abnormal—Prednisone—prostate cancer	0.000102	0.000472	CcSEcCtD
Mianserin—Trimipramine—CYP2C19—prostate cancer	0.000102	0.0174	CrCbGaD
Mianserin—Pruritus—Docetaxel—prostate cancer	0.000102	0.00047	CcSEcCtD
Mianserin—Anaemia—Doxorubicin—prostate cancer	0.000102	0.00047	CcSEcCtD
Mianserin—Myalgia—Epirubicin—prostate cancer	0.000101	0.000468	CcSEcCtD
Mianserin—Arthralgia—Epirubicin—prostate cancer	0.000101	0.000468	CcSEcCtD
Mianserin—Agitation—Doxorubicin—prostate cancer	0.000101	0.000467	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000101	0.000464	CcSEcCtD
Mianserin—Asthenia—Capecitabine—prostate cancer	0.0001	0.000462	CcSEcCtD
Mianserin—Dry mouth—Epirubicin—prostate cancer	9.91e-05	0.000457	CcSEcCtD
Mianserin—Vertigo—Doxorubicin—prostate cancer	9.89e-05	0.000457	CcSEcCtD
Mianserin—Syncope—Doxorubicin—prostate cancer	9.87e-05	0.000456	CcSEcCtD
Mianserin—Pruritus—Capecitabine—prostate cancer	9.86e-05	0.000455	CcSEcCtD
Mianserin—Leukopenia—Doxorubicin—prostate cancer	9.86e-05	0.000455	CcSEcCtD
Mianserin—Confusional state—Epirubicin—prostate cancer	9.79e-05	0.000452	CcSEcCtD
Mianserin—Oedema—Epirubicin—prostate cancer	9.71e-05	0.000448	CcSEcCtD
Mianserin—Loss of consciousness—Doxorubicin—prostate cancer	9.68e-05	0.000447	CcSEcCtD
Mianserin—Shock—Epirubicin—prostate cancer	9.56e-05	0.000441	CcSEcCtD
Mianserin—Convulsion—Doxorubicin—prostate cancer	9.54e-05	0.00044	CcSEcCtD
Mianserin—Nervous system disorder—Epirubicin—prostate cancer	9.52e-05	0.00044	CcSEcCtD
Mianserin—Dizziness—Docetaxel—prostate cancer	9.52e-05	0.00044	CcSEcCtD
Mianserin—Thrombocytopenia—Epirubicin—prostate cancer	9.51e-05	0.000439	CcSEcCtD
Mianserin—Hypertension—Doxorubicin—prostate cancer	9.51e-05	0.000439	CcSEcCtD
Mianserin—Tachycardia—Epirubicin—prostate cancer	9.48e-05	0.000438	CcSEcCtD
Mianserin—Skin disorder—Epirubicin—prostate cancer	9.43e-05	0.000435	CcSEcCtD
Mianserin—Arthralgia—Doxorubicin—prostate cancer	9.37e-05	0.000433	CcSEcCtD
Mianserin—Myalgia—Doxorubicin—prostate cancer	9.37e-05	0.000433	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	9.31e-05	0.00043	CcSEcCtD
Mianserin—Dizziness—Capecitabine—prostate cancer	9.22e-05	0.000426	CcSEcCtD
Mianserin—Dry mouth—Doxorubicin—prostate cancer	9.17e-05	0.000423	CcSEcCtD
Mianserin—Rash—Docetaxel—prostate cancer	9.08e-05	0.000419	CcSEcCtD
Mianserin—Hypotension—Epirubicin—prostate cancer	9.08e-05	0.000419	CcSEcCtD
Mianserin—Dermatitis—Docetaxel—prostate cancer	9.07e-05	0.000419	CcSEcCtD
Mianserin—Confusional state—Doxorubicin—prostate cancer	9.06e-05	0.000418	CcSEcCtD
Mianserin—Headache—Docetaxel—prostate cancer	9.02e-05	0.000416	CcSEcCtD
Mianserin—Desipramine—CYP2E1—prostate cancer	9.01e-05	0.0153	CrCbGaD
Mianserin—Oedema—Doxorubicin—prostate cancer	8.99e-05	0.000415	CcSEcCtD
Mianserin—Desipramine—CYP2C19—prostate cancer	8.92e-05	0.0152	CrCbGaD
Mianserin—Asthenia—Prednisone—prostate cancer	8.91e-05	0.000411	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Epirubicin—prostate cancer	8.85e-05	0.000408	CcSEcCtD
Mianserin—Shock—Doxorubicin—prostate cancer	8.84e-05	0.000408	CcSEcCtD
Mianserin—Nervous system disorder—Doxorubicin—prostate cancer	8.81e-05	0.000407	CcSEcCtD
Mianserin—Thrombocytopenia—Doxorubicin—prostate cancer	8.8e-05	0.000406	CcSEcCtD
Mianserin—Rash—Capecitabine—prostate cancer	8.79e-05	0.000406	CcSEcCtD
Mianserin—Pruritus—Prednisone—prostate cancer	8.79e-05	0.000406	CcSEcCtD
Mianserin—Dermatitis—Capecitabine—prostate cancer	8.78e-05	0.000405	CcSEcCtD
Mianserin—Tachycardia—Doxorubicin—prostate cancer	8.77e-05	0.000405	CcSEcCtD
Mianserin—Headache—Capecitabine—prostate cancer	8.73e-05	0.000403	CcSEcCtD
Mianserin—Skin disorder—Doxorubicin—prostate cancer	8.73e-05	0.000403	CcSEcCtD
Mianserin—Paraesthesia—Epirubicin—prostate cancer	8.72e-05	0.000403	CcSEcCtD
Mianserin—Somnolence—Epirubicin—prostate cancer	8.63e-05	0.000399	CcSEcCtD
Mianserin—Prochlorperazine—CYP3A4—prostate cancer	8.52e-05	0.0145	CrCbGaD
Mianserin—Hypotension—Doxorubicin—prostate cancer	8.4e-05	0.000388	CcSEcCtD
Mianserin—Gastrointestinal disorder—Epirubicin—prostate cancer	8.38e-05	0.000387	CcSEcCtD
Mianserin—Fatigue—Epirubicin—prostate cancer	8.37e-05	0.000386	CcSEcCtD
Mianserin—Constipation—Epirubicin—prostate cancer	8.31e-05	0.000383	CcSEcCtD
Mianserin—Dizziness—Prednisone—prostate cancer	8.21e-05	0.000379	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	8.19e-05	0.000378	CcSEcCtD
Mianserin—Paraesthesia—Doxorubicin—prostate cancer	8.07e-05	0.000372	CcSEcCtD
Mianserin—Feeling abnormal—Epirubicin—prostate cancer	8e-05	0.000369	CcSEcCtD
Mianserin—Somnolence—Doxorubicin—prostate cancer	7.99e-05	0.000369	CcSEcCtD
Mianserin—Rash—Prednisone—prostate cancer	7.83e-05	0.000361	CcSEcCtD
Mianserin—Dermatitis—Prednisone—prostate cancer	7.82e-05	0.000361	CcSEcCtD
Mianserin—Headache—Prednisone—prostate cancer	7.78e-05	0.000359	CcSEcCtD
Mianserin—Gastrointestinal disorder—Doxorubicin—prostate cancer	7.76e-05	0.000358	CcSEcCtD
Mianserin—Fatigue—Doxorubicin—prostate cancer	7.75e-05	0.000358	CcSEcCtD
Mianserin—Constipation—Doxorubicin—prostate cancer	7.68e-05	0.000355	CcSEcCtD
Mianserin—Imipramine—CYP2E1—prostate cancer	7.64e-05	0.013	CrCbGaD
Mianserin—Amitriptyline—CYP2E1—prostate cancer	7.59e-05	0.0129	CrCbGaD
Mianserin—Imipramine—CYP2C19—prostate cancer	7.56e-05	0.0129	CrCbGaD
Mianserin—Amitriptyline—CYP2C19—prostate cancer	7.52e-05	0.0128	CrCbGaD
Mianserin—Feeling abnormal—Doxorubicin—prostate cancer	7.41e-05	0.000342	CcSEcCtD
Mianserin—Asthenia—Epirubicin—prostate cancer	6.97e-05	0.000322	CcSEcCtD
Mianserin—Nortriptyline—CYP3A4—prostate cancer	6.89e-05	0.0117	CrCbGaD
Mianserin—Pruritus—Epirubicin—prostate cancer	6.87e-05	0.000317	CcSEcCtD
Mianserin—Trimipramine—CYP3A4—prostate cancer	6.49e-05	0.011	CrCbGaD
Mianserin—Asthenia—Doxorubicin—prostate cancer	6.45e-05	0.000298	CcSEcCtD
Mianserin—Dizziness—Epirubicin—prostate cancer	6.42e-05	0.000296	CcSEcCtD
Mianserin—Pruritus—Doxorubicin—prostate cancer	6.36e-05	0.000293	CcSEcCtD
Mianserin—Rash—Epirubicin—prostate cancer	6.12e-05	0.000283	CcSEcCtD
Mianserin—Dermatitis—Epirubicin—prostate cancer	6.12e-05	0.000282	CcSEcCtD
Mianserin—Headache—Epirubicin—prostate cancer	6.08e-05	0.000281	CcSEcCtD
Mianserin—Dizziness—Doxorubicin—prostate cancer	5.94e-05	0.000274	CcSEcCtD
Mianserin—Desipramine—CYP3A4—prostate cancer	5.67e-05	0.00966	CrCbGaD
Mianserin—Rash—Doxorubicin—prostate cancer	5.67e-05	0.000262	CcSEcCtD
Mianserin—Dermatitis—Doxorubicin—prostate cancer	5.66e-05	0.000261	CcSEcCtD
Mianserin—Headache—Doxorubicin—prostate cancer	5.63e-05	0.00026	CcSEcCtD
Mianserin—Imipramine—CYP3A4—prostate cancer	4.81e-05	0.00819	CrCbGaD
Mianserin—Amitriptyline—CYP3A4—prostate cancer	4.78e-05	0.00814	CrCbGaD
Mianserin—HTR2C—Signaling Pathways—PTEN—prostate cancer	2.27e-06	1.26e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CTNNB1—prostate cancer	2.26e-06	1.26e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ERCC2—prostate cancer	2.26e-06	1.26e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EP300—prostate cancer	2.25e-06	1.26e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GGT1—prostate cancer	2.25e-06	1.25e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOS3—prostate cancer	2.25e-06	1.25e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL8—prostate cancer	2.23e-06	1.24e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—AKT1—prostate cancer	2.22e-06	1.24e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—prostate cancer	2.22e-06	1.24e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NCOA1—prostate cancer	2.22e-06	1.24e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—AKT1—prostate cancer	2.21e-06	1.23e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CDKN1A—prostate cancer	2.21e-06	1.23e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PTEN—prostate cancer	2.21e-06	1.23e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—PIK3CA—prostate cancer	2.2e-06	1.23e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL8—prostate cancer	2.19e-06	1.22e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—SRC—prostate cancer	2.19e-06	1.22e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL8—prostate cancer	2.18e-06	1.22e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.18e-06	1.22e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—JAK2—prostate cancer	2.18e-06	1.22e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EP300—prostate cancer	2.17e-06	1.21e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MYC—prostate cancer	2.17e-06	1.21e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CDKN1B—prostate cancer	2.17e-06	1.21e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—PIK3CA—prostate cancer	2.17e-06	1.21e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—PIK3CA—prostate cancer	2.17e-06	1.21e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TGFB1—prostate cancer	2.17e-06	1.21e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EP300—prostate cancer	2.16e-06	1.21e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—KRAS—prostate cancer	2.16e-06	1.2e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—PIK3CA—prostate cancer	2.16e-06	1.2e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—prostate cancer	2.15e-06	1.2e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—prostate cancer	2.15e-06	1.2e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTEN—prostate cancer	2.14e-06	1.2e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—PIK3CA—prostate cancer	2.14e-06	1.19e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN1B—prostate cancer	2.14e-06	1.19e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN1B—prostate cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—prostate cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—prostate cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MDM2—prostate cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—prostate cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2—prostate cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—prostate cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EGFR—prostate cancer	2.13e-06	1.19e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—prostate cancer	2.12e-06	1.18e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—prostate cancer	2.12e-06	1.18e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SRC—prostate cancer	2.11e-06	1.18e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—STAT3—prostate cancer	2.11e-06	1.18e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—prostate cancer	2.11e-06	1.18e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.11e-06	1.18e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—RXRA—prostate cancer	2.11e-06	1.18e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EP300—prostate cancer	2.1e-06	1.17e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SRC—prostate cancer	2.1e-06	1.17e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—prostate cancer	2.1e-06	1.17e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—ERBB2—prostate cancer	2.1e-06	1.17e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—prostate cancer	2.1e-06	1.17e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—prostate cancer	2.1e-06	1.17e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2—prostate cancer	2.09e-06	1.17e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—prostate cancer	2.09e-06	1.17e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2—prostate cancer	2.09e-06	1.16e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARA—prostate cancer	2.09e-06	1.16e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—prostate cancer	2.09e-06	1.16e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—prostate cancer	2.08e-06	1.16e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—prostate cancer	2.08e-06	1.16e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCND1—prostate cancer	2.07e-06	1.16e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CB—prostate cancer	2.07e-06	1.16e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—prostate cancer	2.06e-06	1.15e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CTNNB1—prostate cancer	2.05e-06	1.15e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—prostate cancer	2.05e-06	1.14e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SRC—prostate cancer	2.05e-06	1.14e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—EP300—prostate cancer	2.04e-06	1.14e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCND1—prostate cancer	2.04e-06	1.14e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—STAT3—prostate cancer	2.04e-06	1.14e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCND1—prostate cancer	2.04e-06	1.14e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—COMT—prostate cancer	2.03e-06	1.13e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—STAT3—prostate cancer	2.03e-06	1.13e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CTNNB1—prostate cancer	2.02e-06	1.13e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTP1—prostate cancer	2.02e-06	1.13e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CTNNB1—prostate cancer	2.02e-06	1.12e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—prostate cancer	2.01e-06	1.12e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTEN—prostate cancer	2.01e-06	1.12e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—KRAS—prostate cancer	2.01e-06	1.12e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CDKN1A—prostate cancer	2.01e-06	1.12e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PTEN—prostate cancer	2e-06	1.12e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—INS—prostate cancer	2e-06	1.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—prostate cancer	1.99e-06	1.11e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—prostate cancer	1.99e-06	1.11e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ITPR1—prostate cancer	1.99e-06	1.11e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—PIK3CA—prostate cancer	1.98e-06	1.11e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—prostate cancer	1.98e-06	1.1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—prostate cancer	1.98e-06	1.1e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CDKN1A—prostate cancer	1.97e-06	1.1e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—STAT3—prostate cancer	1.97e-06	1.1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CDKN1A—prostate cancer	1.97e-06	1.1e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PTEN—prostate cancer	1.97e-06	1.1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PTEN—prostate cancer	1.96e-06	1.1e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MYC—prostate cancer	1.96e-06	1.09e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAV1—prostate cancer	1.96e-06	1.09e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TGFB1—prostate cancer	1.96e-06	1.09e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CREBBP—prostate cancer	1.95e-06	1.09e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—prostate cancer	1.95e-06	1.09e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—prostate cancer	1.95e-06	1.09e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN1B—prostate cancer	1.95e-06	1.09e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	1.92e-06	1.07e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—prostate cancer	1.92e-06	1.07e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—prostate cancer	1.92e-06	1.07e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—prostate cancer	1.92e-06	1.07e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EGFR—prostate cancer	1.92e-06	1.07e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—prostate cancer	1.92e-06	1.07e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—prostate cancer	1.92e-06	1.07e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—EP300—prostate cancer	1.92e-06	1.07e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—prostate cancer	1.91e-06	1.06e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EP300—prostate cancer	1.91e-06	1.06e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—prostate cancer	1.91e-06	1.06e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2—prostate cancer	1.9e-06	1.06e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—prostate cancer	1.89e-06	1.06e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MYC—prostate cancer	1.89e-06	1.06e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.89e-06	1.05e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MYC—prostate cancer	1.88e-06	1.05e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TGFB1—prostate cancer	1.88e-06	1.05e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—TYMS—prostate cancer	1.88e-06	1.05e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EP300—prostate cancer	1.88e-06	1.05e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EP300—prostate cancer	1.87e-06	1.05e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.87e-06	1.05e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PIK3CA—prostate cancer	1.86e-06	1.04e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTM1—prostate cancer	1.86e-06	1.04e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCND1—prostate cancer	1.86e-06	1.04e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SRC—prostate cancer	1.86e-06	1.04e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.85e-06	1.03e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.85e-06	1.03e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—PIK3CA—prostate cancer	1.84e-06	1.03e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EGFR—prostate cancer	1.84e-06	1.03e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	1.84e-06	1.03e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MYC—prostate cancer	1.83e-06	1.02e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TGFB1—prostate cancer	1.83e-06	1.02e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SRC—prostate cancer	1.83e-06	1.02e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—LPL—prostate cancer	1.82e-06	1.02e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SRC—prostate cancer	1.82e-06	1.02e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—KRAS—prostate cancer	1.81e-06	1.01e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—prostate cancer	1.81e-06	1.01e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—prostate cancer	1.8e-06	1.01e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—prostate cancer	1.8e-06	1e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	1.8e-06	1e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EGFR—prostate cancer	1.79e-06	1e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PTEN—prostate cancer	1.79e-06	9.99e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—STAT3—prostate cancer	1.79e-06	9.98e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.79e-06	9.96e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—prostate cancer	1.78e-06	9.96e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—prostate cancer	1.78e-06	9.92e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—prostate cancer	1.77e-06	9.9e-06	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—prostate cancer	1.77e-06	9.9e-06	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—prostate cancer	1.77e-06	9.89e-06	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—prostate cancer	1.76e-06	9.82e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—STAT3—prostate cancer	1.76e-06	9.82e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.76e-06	9.82e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—STAT3—prostate cancer	1.76e-06	9.8e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—prostate cancer	1.76e-06	9.79e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NOS3—prostate cancer	1.75e-06	9.76e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—KRAS—prostate cancer	1.75e-06	9.76e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	1.75e-06	9.75e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ERCC2—prostate cancer	1.75e-06	9.74e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—KRAS—prostate cancer	1.74e-06	9.71e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EP300—prostate cancer	1.71e-06	9.53e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—KRAS—prostate cancer	1.69e-06	9.45e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—INS—prostate cancer	1.69e-06	9.43e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—PIK3CA—prostate cancer	1.67e-06	9.29e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MYC—prostate cancer	1.66e-06	9.28e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SRC—prostate cancer	1.66e-06	9.27e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TGFB1—prostate cancer	1.66e-06	9.25e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CREBBP—prostate cancer	1.66e-06	9.24e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—prostate cancer	1.64e-06	9.15e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MYC—prostate cancer	1.64e-06	9.13e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—prostate cancer	1.63e-06	9.11e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MYC—prostate cancer	1.63e-06	9.11e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TGFB1—prostate cancer	1.63e-06	9.11e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TGFB1—prostate cancer	1.63e-06	9.09e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EGFR—prostate cancer	1.63e-06	9.07e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—prostate cancer	1.62e-06	9.04e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	1.62e-06	9.03e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.62e-06	9.01e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—prostate cancer	1.61e-06	8.99e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARA—prostate cancer	1.61e-06	8.98e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	1.61e-06	8.97e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—STAT3—prostate cancer	1.6e-06	8.94e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—prostate cancer	1.6e-06	8.93e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EGFR—prostate cancer	1.6e-06	8.93e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	1.6e-06	8.92e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EGFR—prostate cancer	1.6e-06	8.91e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.57e-06	8.76e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—PIK3CA—prostate cancer	1.56e-06	8.68e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—prostate cancer	1.56e-06	8.68e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—prostate cancer	1.55e-06	8.63e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—KRAS—prostate cancer	1.54e-06	8.57e-06	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—prostate cancer	1.52e-06	8.48e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAV1—prostate cancer	1.51e-06	8.44e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—KRAS—prostate cancer	1.51e-06	8.43e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3CA—prostate cancer	1.51e-06	8.43e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—KRAS—prostate cancer	1.51e-06	8.42e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—prostate cancer	1.51e-06	8.41e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—prostate cancer	1.51e-06	8.4e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MYC—prostate cancer	1.49e-06	8.3e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	1.48e-06	8.28e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NOS3—prostate cancer	1.48e-06	8.27e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—prostate cancer	1.47e-06	8.23e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EGFR—prostate cancer	1.46e-06	8.12e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—prostate cancer	1.42e-06	7.94e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.42e-06	7.9e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—prostate cancer	1.42e-06	7.9e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3CA—prostate cancer	1.41e-06	7.88e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTEN—prostate cancer	1.4e-06	7.79e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	1.39e-06	7.75e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.39e-06	7.73e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.38e-06	7.69e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—prostate cancer	1.38e-06	7.69e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—KRAS—prostate cancer	1.38e-06	7.67e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.37e-06	7.63e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—prostate cancer	1.37e-06	7.62e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—prostate cancer	1.36e-06	7.59e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—prostate cancer	1.36e-06	7.56e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—prostate cancer	1.34e-06	7.5e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—prostate cancer	1.34e-06	7.48e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—EP300—prostate cancer	1.33e-06	7.43e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—prostate cancer	1.31e-06	7.33e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—prostate cancer	1.31e-06	7.29e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—INS—prostate cancer	1.3e-06	7.28e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CREBBP—prostate cancer	1.28e-06	7.13e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—prostate cancer	1.27e-06	7.09e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	1.26e-06	7.05e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—prostate cancer	1.25e-06	6.97e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—prostate cancer	1.23e-06	6.89e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—prostate cancer	1.23e-06	6.86e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—prostate cancer	1.23e-06	6.85e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—prostate cancer	1.22e-06	6.82e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.21e-06	6.76e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTEN—prostate cancer	1.18e-06	6.6e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—prostate cancer	1.16e-06	6.46e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—prostate cancer	1.15e-06	6.43e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NOS3—prostate cancer	1.14e-06	6.38e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—prostate cancer	1.13e-06	6.33e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—prostate cancer	1.13e-06	6.32e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—EP300—prostate cancer	1.13e-06	6.29e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—prostate cancer	1.12e-06	6.24e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.06e-06	5.89e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—prostate cancer	1.05e-06	5.84e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—prostate cancer	1.03e-06	5.76e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3CA—prostate cancer	9.85e-07	5.49e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTEN—prostate cancer	9.13e-07	5.09e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—EP300—prostate cancer	8.7e-07	4.86e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3CA—prostate cancer	8.34e-07	4.65e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—prostate cancer	8.04e-07	4.49e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—prostate cancer	6.81e-07	3.8e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3CA—prostate cancer	6.44e-07	3.59e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—prostate cancer	5.26e-07	2.93e-06	CbGpPWpGaD
